Emilio B. González

2.0k total citations
46 papers, 1.0k citations indexed

About

Emilio B. González is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Emilio B. González has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 14 papers in Pathology and Forensic Medicine and 13 papers in Immunology. Recurrent topics in Emilio B. González's work include Systemic Lupus Erythematosus Research (15 papers), Systemic Sclerosis and Related Diseases (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Emilio B. González is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Systemic Sclerosis and Related Diseases (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Emilio B. González collaborates with scholars based in United States, Singapore and United Kingdom. Emilio B. González's co-authors include Maureen D. Mayes, Shervin Assassi, Silvia S. Pierangeli, Hilda T. Draeger, John D. Reveille, Brock E. Harper, Pojen P. Chen, Frank C. Arnett, Rohan Willis and Jerry C. Daniels and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Emilio B. González

44 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emilio B. González United States 19 448 440 274 211 210 46 1.0k
Yong Hou China 20 386 0.9× 433 1.0× 250 0.9× 316 1.5× 139 0.7× 77 1.0k
Francisco José García Hernández Spain 17 566 1.3× 260 0.6× 212 0.8× 398 1.9× 353 1.7× 71 1.3k
Massimiliano Cazzato Italy 12 523 1.2× 647 1.5× 287 1.0× 239 1.1× 359 1.7× 25 1.4k
Cándido Díaz‐Lagares Spain 19 704 1.6× 224 0.5× 277 1.0× 357 1.7× 346 1.6× 25 1.5k
R. Pérez-Álvarez Spain 19 599 1.3× 207 0.5× 488 1.8× 302 1.4× 343 1.6× 25 1.6k
M. Pérez-de-Lis Spain 17 411 0.9× 167 0.4× 263 1.0× 242 1.1× 309 1.5× 20 1.2k
Guillaume Bussone France 16 135 0.3× 333 0.8× 388 1.4× 247 1.2× 142 0.7× 31 904
M. Vanoli Italy 15 254 0.6× 278 0.6× 394 1.4× 291 1.4× 107 0.5× 35 942
Hayato Nagasawa Japan 19 792 1.8× 204 0.5× 176 0.6× 193 0.9× 278 1.3× 51 1.1k
E. L. Matteson United States 19 967 2.2× 240 0.5× 683 2.5× 161 0.8× 184 0.9× 36 1.6k

Countries citing papers authored by Emilio B. González

Since Specialization
Citations

This map shows the geographic impact of Emilio B. González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio B. González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio B. González more than expected).

Fields of papers citing papers by Emilio B. González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio B. González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio B. González. The network helps show where Emilio B. González may publish in the future.

Co-authorship network of co-authors of Emilio B. González

This figure shows the co-authorship network connecting the top 25 collaborators of Emilio B. González. A scholar is included among the top collaborators of Emilio B. González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilio B. González. Emilio B. González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González, Emilio B., et al.. (2023). Multisystem inflammatory syndrome in adults associated with COVID‐19: A rare life‐threatening complication. SHILAP Revista de lepidopterología. 3(4). 247–249.
2.
Willis, Rohan, Thomas McDonnell, Charis Pericleous, et al.. (2022). PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome. Frontiers in Immunology. 13. 842923–842923. 6 indexed citations
3.
Shemer, Asaf, Rohan Willis, Emilio B. González, et al.. (2019). Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome. Journal of Autoimmunity. 99. 98–103. 14 indexed citations
4.
McDonnell, Thomas, Rohan Willis, Charis Pericleous, et al.. (2018). PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome. Frontiers in Immunology. 9. 2413–2413. 18 indexed citations
5.
Willis, Rohan, Edward N. Harris, Elizabeth Papalardo, et al.. (2018). Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin. American Journal of Clinical Pathology. 149(5). 401–411. 10 indexed citations
6.
Willis, Rohan, Gerald McGwin, Laura-Aline Martínez-Martínez, et al.. (2014). Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort.. PubMed. 32(2). 162–7. 19 indexed citations
7.
Charles, Julio, Claudia Pedroza, Xiaochun Liu, et al.. (2013). Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis?. The Journal of Rheumatology. 40(7). 1114–1120. 47 indexed citations
8.
Draeger, Hilda T., Shervin Assassi, Roozbeh Sharif, et al.. (2013). Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis. PLoS ONE. 8(10). e78808–e78808. 37 indexed citations
9.
Liu, Xiaochun, Maureen D. Mayes, Filemon K. Tan, et al.. (2012). Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis. Arthritis & Rheumatism. 65(1). 226–235. 78 indexed citations
10.
Sharif, Roozbeh, Maureen D. Mayes, Filemon K. Tan, et al.. (2012). IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 71(7). 1197–1202. 56 indexed citations
11.
Merz, Erin L., Vanessa L. Malcarne, Scott C. Roesch, et al.. (2012). Measuring Illness Behavior in Patients With Systemic Sclerosis. Arthritis Care & Research. 65(4). 585–593. 7 indexed citations
12.
Sharif, Roozbeh, Maureen D. Mayes, Perry M. Nicassio, et al.. (2011). Determinants of Work Disability in Patients with Systemic Sclerosis: A Longitudinal Study of the GENISOS Cohort. Seminars in Arthritis and Rheumatism. 41(1). 38–47. 32 indexed citations
13.
González, Emilio B.. (2011). An update on the pathology and clinical management of gouty arthritis. Clinical Rheumatology. 31(1). 13–21. 35 indexed citations
14.
Nguyen, Binh, Maureen D. Mayes, Frank C. Arnett, et al.. (2010). HLA–DRB1*0407 and *1304 are risk factors for scleroderma renal crisis. Arthritis & Rheumatism. 63(2). 530–534. 50 indexed citations
15.
González, Emilio B.. (2007). Nonsteroidal antiinflammatory drugs did not increase risk for all-cause mortality in osteoarthritis. ACP Journal Club. 146(3). 77–77. 1 indexed citations
16.
Pierangeli, Silvia S., Mariano E. Vega-Ostertag, & Emilio B. González. (2007). New targeted therapies for treatment of thrombosis in antiphospholipid syndrome. Expert Reviews in Molecular Medicine. 9(30). 1–15. 24 indexed citations
17.
Sunkureddi, Prashanth, et al.. (2005). A 39-year-old man with sudden onset of chest pain.. Cleveland Clinic Journal of Medicine. 72(11). 1050–1056. 1 indexed citations
18.
González, Emilio B., et al.. (1995). Severe anemia as the presenting manifestation of giant cell arteritis. Arthritis & Rheumatism. 38(3). 434–436. 17 indexed citations
19.
González, Emilio B., et al.. (1985). Defective expression of OKT4 antigen on the cell surface of helper T lymphocytes in a patient with systemic lupus erythematosus.. PubMed. 1(4). 299–305. 1 indexed citations
20.
Ichikawa, Yukinobu, Emilio B. González, & Jerry C. Daniels. (1982). Suppressor cells of mitogen-induced lymphocyte proliferation in the peripheral blood of patients with common variable hypogammaglobulinemia. Clinical Immunology and Immunopathology. 25(2). 252–263. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Hou Breakdown of academic impact, for papers by Francisco José García Hernández Breakdown of academic impact, for papers by Massimiliano Cazzato Breakdown of academic impact, for papers by Cándido Díaz‐Lagares Breakdown of academic impact, for papers by R. Pérez-Álvarez Breakdown of academic impact, for papers by M. Pérez-de-Lis Breakdown of academic impact, for papers by Guillaume Bussone Breakdown of academic impact, for papers by M. Vanoli Breakdown of academic impact, for papers by Hayato Nagasawa Breakdown of academic impact, for papers by E. L. Matteson
Rankless by CCL
2026